ORIFARM A/S: Financial statements 2013
CVR: 26058708
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
ORIFARM A/S (CVR 26058708) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 1,078,460,000 and a net result of DKK 4,473,000. The profit margin was 0.4%. Equity in the 2013 report amounted to DKK 18,362,000. The solvency ratio was 8.6%.
- Revenue
- DKK 1,078,460,000
- Gross Profit
- DKK 42,247,000
- Profit/Loss
- DKK 4,473,000
- Equity
- DKK 18,362,000
- Total Assets
- DKK 213,815,000
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
ORIFARM A/S has published its annual report for 2012.
About ORIFARM A/S
ORIFARM A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JUT NR. 2181 A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM PI A/S. The company has 39 employees (2026). In 2025, the company reported revenue of DKK 1,174,659,000 and a net result of DKK 9,727,000 compared with DKK 14,865,000 the year before. Equity in the 2025 report amounted to DKK 44,048,000.